Autopsy report · NCT03185780

Complementary/Integrative Medicine for Brain Cancer Patients

“Unable to attain funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

The Chaim Sheba Medical Center

Sponsor type

University, hospital or other

Conditions

Quality of Life; Chemotherapeutic Toxicity; Radiation Toxicity

Interventions

Acupuncture

Participants

0

Trials that died the same way

• Biomarkers for Bipolar Disorder: Chaperones and Reticulum Endoplasmatic Stress Response CHAP´s Study
  “fail to get funding” (91% match in meaning)
• Study to Determine Pediatric Bladder Volume Prior to Catheterization
  “Inability to obtain grant funding” (88% match in meaning)
• Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room
  “Unable to obtain funding to initiate/complete study” (86% match in meaning)
• Targeting Leukotrienes in Kidney Disease
  “Funding not available” (85% match in meaning)
• Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction
  “Failed to gain funding” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.